GlassScriptPhysician profile
Nejat Destani
NPI 1295738771
$614.17
in general payments reported to CMS, 2019-2025
19 companies · $76.55 in 2025
The $76.55 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $51.57 · 2021: $29.19 · 2022: $50.06 · 2023: $76.99 · 2024: $111 · 2025: $76.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.55 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $63.66 | 2019-2023 | Trulicity, Mounjaro |
| Novo Nordisk INC | $52.97 | 2019-2021 | |
| Abbott Laboratories | $50.06 | 2022 | |
| Merck Sharp & Dohme LLC | $43.10 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Janssen Pharmaceuticals, INC | $34.60 | 2019-2021 | |
| Pfizer INC. | $32.84 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $28.80 | 2023-2025 | Farxiga |
| Sanofi Pasteur INC. | $23.81 | 2024 | |
| Glaxosmithkline, LLC. | $23.76 | 2023 | Shingrix, Arexvy |
| Globus Medical, INC. | $22.32 | 2025 | Senza |
| Abbvie INC. | $21.82 | 2024 | |
| Exact Sciences Corporation | $20.70 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $20.37 | 2019 | |
| Cranial Technologies, INC | $17.52 | 2025 | Doc Band |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.79 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.76 | 2019 | |
| Amgen INC. | $11.89 | 2019 | |
| Eisai INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nejat Destani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.